FR3001217B1 - Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations - Google Patents

Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations

Info

Publication number
FR3001217B1
FR3001217B1 FR1300125A FR1300125A FR3001217B1 FR 3001217 B1 FR3001217 B1 FR 3001217B1 FR 1300125 A FR1300125 A FR 1300125A FR 1300125 A FR1300125 A FR 1300125A FR 3001217 B1 FR3001217 B1 FR 3001217B1
Authority
FR
France
Prior art keywords
triazamacrocycle
synthesis
compositions
compounds
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1300125A
Other languages
English (en)
Other versions
FR3001217A1 (fr
Inventor
Stephane Moutard
Vincent Delauzun
Laurent Meunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOCELLCHALLENGE
Original Assignee
BIOCELLCHALLENGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOCELLCHALLENGE filed Critical BIOCELLCHALLENGE
Priority to FR1300125A priority Critical patent/FR3001217B1/fr
Priority to PCT/FR2014/000013 priority patent/WO2014111639A1/fr
Priority to US14/762,101 priority patent/US9822083B2/en
Priority to EP14704380.6A priority patent/EP2945935A1/fr
Priority to CA2898081A priority patent/CA2898081A1/fr
Publication of FR3001217A1 publication Critical patent/FR3001217A1/fr
Application granted granted Critical
Publication of FR3001217B1 publication Critical patent/FR3001217B1/fr
Priority to US15/297,529 priority patent/US20170035886A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FR1300125A 2013-01-21 2013-01-21 Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations Expired - Fee Related FR3001217B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1300125A FR3001217B1 (fr) 2013-01-21 2013-01-21 Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations
PCT/FR2014/000013 WO2014111639A1 (fr) 2013-01-21 2014-01-21 Derives amphiphiles de composes tr1azamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations
US14/762,101 US9822083B2 (en) 2013-01-21 2014-01-21 Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
EP14704380.6A EP2945935A1 (fr) 2013-01-21 2014-01-21 Derives amphiphiles de composes tr1azamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations
CA2898081A CA2898081A1 (fr) 2013-01-21 2014-01-21 Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations
US15/297,529 US20170035886A1 (en) 2013-01-21 2016-10-19 Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1300125A FR3001217B1 (fr) 2013-01-21 2013-01-21 Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations

Publications (2)

Publication Number Publication Date
FR3001217A1 FR3001217A1 (fr) 2014-07-25
FR3001217B1 true FR3001217B1 (fr) 2015-08-14

Family

ID=48044840

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1300125A Expired - Fee Related FR3001217B1 (fr) 2013-01-21 2013-01-21 Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations

Country Status (5)

Country Link
US (1) US9822083B2 (fr)
EP (1) EP2945935A1 (fr)
CA (1) CA2898081A1 (fr)
FR (1) FR3001217B1 (fr)
WO (1) WO2014111639A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117088825A (zh) * 2023-10-12 2023-11-21 成都威斯津生物医药科技有限公司 一种可离子化脂质、含该可离子化脂质的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744335A (en) * 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
AU2637500A (en) * 1999-12-10 2001-06-18 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
EP1261620A2 (fr) * 2000-02-07 2002-12-04 Roche Diagnostics Corporation Nouveaux amphiphiles cationiques
FR2860232B1 (fr) * 2003-09-26 2006-01-27 Oreal Derives de triacyclonane substitue sur l'un au moins des atomes d'azote par un groupement 4'-aminophenyle substitue ou non substitue pour la teinture des fibres keratiniques
WO2009129385A1 (fr) * 2008-04-16 2009-10-22 Abbott Laboratories Lipides cationiques et utilisations de ceux-ci
KR101106433B1 (ko) * 2009-04-03 2012-01-18 서울대학교산학협력단 암 조직의 타겟팅을 위한 마크로사이클릭 아미노산 계열의 유도체 및 그의 방사성 또는 비방사성 금속 표지화합물

Also Published As

Publication number Publication date
US20150353514A1 (en) 2015-12-10
WO2014111639A1 (fr) 2014-07-24
US9822083B2 (en) 2017-11-21
EP2945935A1 (fr) 2015-11-25
CA2898081A1 (fr) 2014-07-24
FR3001217A1 (fr) 2014-07-25

Similar Documents

Publication Publication Date Title
HK1250233A1 (zh) 新的羥基酸衍生物、其製備方法以及含有它們的藥物組合物
IL244399A (en) Preparations based on terpenes, processes and methodologies for their production and products produced through them
IL256609B (en) Pyridine derivatives, their preparation and pharmaceutical compositions containing them
IL256610B (en) Pyrimidine history, their preparation and pharmaceutical preparations containing them
EP3283453A4 (fr) Revêtements et additifs contenant des acides gras, des sels d'acides gras ou des composés similaires, destinés à être utilisés comme agents dépoussiérants et/ou antiagglomérants pour produits granulaires
FR3037965B1 (fr) Compositions de primaire de revetement antiadhesif et leurs procedes de preparation
IL258160B (en) Biaryl derivatives, pharmaceutical preparations containing them and their uses
IL239054A0 (en) History of azaquinazoline carboxamide, their preparation and pharmaceutical preparations containing them
IL238060B (en) 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them
DK3508196T3 (da) Aripiprazol-prodrugsammensætninger
CY1117210T1 (el) Παραγωγα 2-οξο-1-ιμιδαζολιδινυλ ιμιδαζοθειαδιαζολης
IL258977B (en) Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them
MA44079A (fr) Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine
SMP201500110B (it) Prodotto alimentare ripieno, nonche' metodo di produzione di tale prodotto alimentare
ITTO20130356A1 (it) Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi
IL256705A (en) History of pyridine and pirazine, their preparation and pharmaceutical preparations containing them
FR2974089B1 (fr) Derives de l'acadesine, produits et compositions les comprenant, leurs utilisations therapeutiques et leurs procedes de synthese.
FR3001217B1 (fr) Derives amphiphiles de composes triazamacrocycles, produits et compositions les comprenant, leurs procedes de synthese et leurs utilisations
FR2986527B1 (fr) Procede de preparation de phosphines tertiaires et de derives de celles-ci.
FR3006314B1 (fr) Nouveau procede de synthese de derives n-alkyl-glycosyl(di)amine et leurs applications
FR3011070B1 (fr) Sechoir pour produits en terre
FR3026009B1 (fr) Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants
FR3014871B1 (fr) Composes ferroceniques fonctionnalises dissymetrisables a conformation controlee, leurs procedes de synthese et leurs applications
DK3182958T4 (da) Aripiprazol-prodrugsammensætninger
DK2953617T3 (da) Farmaceutiske sammensætninger, der inkorporerer lavdosislægemidler

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20180928